Shares of Thermo Fisher Scientific Inc. TMO rose 1.10% to $528.96 Friday, on what proved to be an all-around positive trading ...

As tariffs loom, 3M spinoff Solventum’s operating margins are continuing to shrink, and its investors are looking toward the company’s announced purification business sale for balance sheet relief.

The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, according to Marc N. Casper, chairman, president, and CEO of Thermo Fisher.

Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...

Swiss public transport company, Regionalverkehr Bern-Solothurn (RBS), made its debut in the public market on Thursday. The ...

Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory ...

Weitz Investment Management, an investment management firm, released its “Partners III Opportunity Fund” fourth-quarter 2024 ...

Thermo Fisher Scientific launched the CorEvitas Systemic Lupus Erythematosus Registry to advance lupus research. The ...

This useful study presents findings on the developmental roles of Nup107, a key nucleoporin, in regulating the larval-to-pupal transition in Drosophila melanogaster through its involvement in ecdysone ...

Shares of Thermo Fisher Scientific Inc. TMO shed 1.89% to $523.23 Thursday, on what proved to be an all-around rough trading ...

Thermo Fisher Scientific Inc. (Waltham, Mass.) announced that the company has entered into a definitive agreement with Solventum  to acquire Solventum’s ...

Jim Cramer was recently asked about Danaher Corporation (NYSE:DHR) on CNBC. Cramer praised the company’s management and said ...